Peregrine Asset Advisers’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-3,000
Closed -$279K 106
2017
Q3
$279K Hold
3,000
0.15% 67
2017
Q2
$272K Hold
3,000
0.17% 66
2017
Q1
$263K Hold
3,000
0.14% 70
2016
Q4
$249K Hold
3,000
0.15% 88
2016
Q3
$278K Buy
+3,000
New +$278K 0.17% 84